Display options
Cite
Wang Y, Wang Q, Song J. Inhibition of autophagy potentiates the proliferation inhibition activity of microRNA-7 in human hepatocellular carcinoma cells. Oncol Lett. 2017;14(3):3566-3572doi: 10.3892/ol.2017.6573.
Wang, Y., Wang, Q., & Song, J. (2017). Inhibition of autophagy potentiates the proliferation inhibition activity of microRNA-7 in human hepatocellular carcinoma cells. Oncology letters, 14(3), 3566-3572. https://doi.org/10.3892/ol.2017.6573
Wang, Yanna, et al. "Inhibition of autophagy potentiates the proliferation inhibition activity of microRNA-7 in human hepatocellular carcinoma cells." Oncology letters vol. 14,3 (2017): 3566-3572. doi: https://doi.org/10.3892/ol.2017.6573
Wang Y, Wang Q, Song J. Inhibition of autophagy potentiates the proliferation inhibition activity of microRNA-7 in human hepatocellular carcinoma cells. Oncol Lett. 2017 Sep;14(3):3566-3572. doi: 10.3892/ol.2017.6573. Epub 2017 Jul 15. PMID: 28927113; PMCID: PMC5588049.
Copy Download .nbib Format: NLM
Share it on

Oncol Lett. 2017 Sep;14(3):3566-3572. doi: 10.3892/ol.2017.6573. Epub 2017 Jul 15.

Inhibition of autophagy potentiates the proliferation inhibition activity of microRNA-7 in human hepatocellular carcinoma cells.

Oncology letters

Yanna Wang, Qiaoling Wang, Jiqing Song

Affiliations

  1. Department of Infectious Diseases, Yantai Hospital For Infectious Diseases, Yantai, Shandong 264001, P.R. China.
  2. Nursing Department of Yantai Yeda Hospital, Yantai, Shandong 264006, P.R. China.

PMID: 28927113 PMCID: PMC5588049 DOI: 10.3892/ol.2017.6573

Abstract

MicroRNAs (miRNAs/miRs) are important molecules that are able to regulate multiple cellular processes in cancer cells. miR-7 has been previously identified as a tumor suppressive miRNA in several types of cancer. The aim of the present study was to investigate whether miR-7 is able to regulate autophagy in hepatocellular carcinoma (HCC) cells. It was identified that miR-7 was significantly downregulated in tumor tissues compared with adjacent normal tissues. Overexpression of miR-7 inhibited cell proliferative activity, which was partially reversed by miR-7 inhibitor. In addition, overexpression of miR-7 significantly induced an increasen in autophagic activity, and luciferase activity assay and western blot analysis identified that mammalian target of rapamycin (mTOR) was a direct target of miR-7. In addition, inhibition of autophagy by 3-methyladenine resulted in a marked enhancement of the proliferation inhibition effect of miR-7. In conclusion, miR-7 was identified to induce proliferation inhibition and autophagy in HCC cells by targeting mTOR, and inhibition of autophagy may be utilized to enhance the antitumor activity of miR-7.

Keywords: autophagy; hepatocellular carcinoma; mammalian target of rapamycin; microRNA-7

References

  1. Oncol Rep. 2014 Apr;31(4):1715-22 - PubMed
  2. J Clin Exp Hepatol. 2014 Mar;4(1):51-9 - PubMed
  3. Front Oncol. 2017 Apr 18;7:65 - PubMed
  4. J Clin Med. 2015 Aug 25;4(9):1668-87 - PubMed
  5. Methods. 2001 Dec;25(4):402-8 - PubMed
  6. J Hepatocell Carcinoma. 2016 Oct 05;3:41-53 - PubMed
  7. Toxicology. 2014 Dec 4;326:9-17 - PubMed
  8. Mol Med Rep. 2015 Oct;12 (4):5443-8 - PubMed
  9. Cancers (Basel). 2017 May 09;9(5):null - PubMed
  10. Hepatology. 2014 Feb;59(2):505-17 - PubMed
  11. Anticancer Res. 2014 Dec;34(12):6887-96 - PubMed
  12. Biochim Biophys Acta. 2008 Nov;1779(11):663-7 - PubMed
  13. Oncotarget. 2017 Apr 25;8(17 ):29519-29534 - PubMed
  14. Mol Oncol. 2015 Oct;9(8):1501-9 - PubMed
  15. Hepatology. 2012 Jun;55(6):1852-62 - PubMed
  16. Age (Dordr). 2014 Jun;36(3):9626 - PubMed
  17. Int J Cancer. 2012 Dec 15;131(12):2939-50 - PubMed
  18. Semin Cancer Biol. 2017 Jun;44:132-140 - PubMed
  19. Oncotarget. 2015 Oct 6;6(30):28867-81 - PubMed
  20. J Clin Transl Hepatol. 2014 Dec;2(4):253-8 - PubMed
  21. Cancer Lett. 2015 Mar 28;358(2):180-90 - PubMed
  22. FEBS Lett. 2010 Apr 2;584(7):1287-95 - PubMed
  23. Drug Dev Res. 2015 Nov;76(7):357-67 - PubMed
  24. Biochem Biophys Res Commun. 2014 Jan 17;443(3):1078-84 - PubMed
  25. Oncol Rep. 2012 Jan;27(1):143-50 - PubMed
  26. Future Med Chem. 2015 Aug;7(12):1535-42 - PubMed
  27. Cell Death Differ. 2015 Jun;22(6):1025-34 - PubMed
  28. Nature. 2008 Feb 28;451(7182):1069-75 - PubMed
  29. Autophagy. 2016 Aug 2;12(8):1355-71 - PubMed
  30. Oncotarget. 2015 Sep 15;6(27):24017-31 - PubMed
  31. Int J Biochem Cell Biol. 2014 Sep;54:312-7 - PubMed
  32. Biomed Res Int. 2014;2014:735672 - PubMed
  33. CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90 - PubMed
  34. Cell. 2008 Jan 11;132(1):27-42 - PubMed
  35. Int J Biol Sci. 2011;7(6):805-14 - PubMed
  36. Ann Surg Oncol. 2010 May;17(5):1247-56 - PubMed

Publication Types